Ameritas Investment Partners’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $133K | Hold |
6,544
| – | – | ﹤0.01% | 1561 |
|
|
2025
Q1 | $119K | Hold |
6,544
| – | – | ﹤0.01% | 1584 |
|
|
2024
Q4 | $165K | Hold |
6,544
| – | – | 0.01% | 1434 |
|
|
2024
Q3 | $222K | Buy |
6,544
+346
| +6% | +$11.8K | 0.01% | 1249 |
|
|
2024
Q2 | $229K | Hold |
6,198
| – | – | 0.01% | 1174 |
|
|
2024
Q1 | $260K | Buy |
6,198
+1,582
| +34% | +$66.4K | 0.01% | 1122 |
|
|
2023
Q4 | $183K | Hold |
4,616
| – | – | 0.01% | 1320 |
|
|
2023
Q3 | $127K | Buy |
4,616
+779
| +20% | +$21.4K | 0.01% | 1488 |
|
|
2023
Q2 | $130K | Buy |
3,837
+312
| +9% | +$10.6K | ﹤0.01% | 1408 |
|
|
2023
Q1 | $127K | Hold |
3,525
| – | – | 0.01% | 1373 |
|
|
2022
Q4 | $164K | Hold |
3,525
| – | – | 0.01% | 1267 |
|
|
2022
Q3 | $99K | Hold |
3,525
| – | – | ﹤0.01% | 1493 |
|
|
2022
Q2 | $95K | Hold |
3,525
| – | – | ﹤0.01% | 1544 |
|
|
2022
Q1 | $120K | Hold |
3,525
| – | – | ﹤0.01% | 1511 |
|
|
2021
Q4 | $136K | Hold |
3,525
| – | – | ﹤0.01% | 1498 |
|
|
2021
Q3 | $190K | Buy |
3,525
+451
| +15% | +$24.3K | 0.01% | 1237 |
|
|
2021
Q2 | $103K | Buy |
+3,074
| New | +$103K | ﹤0.01% | 1705 |
|
|
2018
Q2 | – | Sell |
-690
| Closed | -$24K | – | 3008 |
|
|
2018
Q1 | $24K | Hold |
690
| – | – | ﹤0.01% | 2319 |
|
|
2017
Q4 | $29K | Buy |
690
+183
| +36% | +$7.69K | ﹤0.01% | 2237 |
|
|
2017
Q3 | $18K | Hold |
507
| – | – | ﹤0.01% | 2474 |
|
|
2017
Q2 | $19K | Hold |
507
| – | – | ﹤0.01% | 2478 |
|
|
2017
Q1 | $27K | Buy |
+507
| New | +$27K | ﹤0.01% | 2225 |
|
|
2015
Q2 | – | Sell |
-524
| Closed | -$219K | – | 1173 |
|
|
2015
Q1 | $219K | Buy |
+524
| New | +$219K | 0.01% | 972 |
|
|
2013
Q4 | – | Sell |
-477
| Closed | -$253K | – | 1065 |
|
|
2013
Q3 | $253K | Buy |
+477
| New | +$253K | 0.02% | 826 |
|